1 Current assays to detect allergen-specific IgE have constraints related to obtaining pure, 2 conformationally active allergen, variability in allergen extracts, sample volume required, and 3 turnaround time. The luciferase immunoprecipitation systems (LIPS) immunoassay is a fast, 4 sensitive assay created using recombinant antigens that requires a low specimen volume. These 5 assays can also be easily modified to detect multiple antigens and antibody isotypes. Here, we 6 demonstrate the use of LIPS assays as an innovative method to quantitatively measure allergen 7 component-specific IgE in small sample volumes. Sera from healthy volunteers, helminth-8 infected adults, and peanut-allergic children were screened for IgE to cat using ImmunoCAP. 9 These samples were also measured for IgE against Fel d 1 using LIPS. LIPS signal correlated to 10 cat IgE levels with r S = 0.6204, p < 0.001. The LIPS signal : noise ratio differed significantly 11 between cat IgE-samples and cat IgE+ samples with values > 0.5 kU/L, with the ability to 12 differentiate cat IgE -individuals from cat IgE+ individuals with 85% sensitivity and 76% 13 specificity. Given their rapidity, efficiency, sensitivity, and quantitation over a broad dynamic 14 range, LIPS immunoassays can be a robust and flexible tool with potential uses in allergy 15 research, diagnostics, and treatment.
Introduction 18
Current laboratory methods to determine the presence of circulating allergen-specific IgE 19 involve the use of crude biological extracts or purified recombinant allergens. 1 Extracts may 20 differ in composition due to difficulties in obtaining a pure, raw material, and/or differences in 21 processing, 1, 2 and recombinant allergens are difficult to obtain in biologically relevant, 22 conformationally active forms. 2. These limitations with the allergen can lead to variable results 23 in assays. 1 In addition, challenges arise in patients undergoing evaluation for multiple allergens 24 with restrictions on blood draw volume, such as children. All of these constraints indicate a need 25 for an efficient and sensitive assay using small sample volumes and recombinant proteins. The 26 luciferase immunoprecipitation systems (LIPS) immunoassay has been shown to be an effective 27 method of detection of autoantibodies and antibodies against infectious agents with high 28 sensitivity and specificity. 3 Advantages of this method over other assays for antibody detection 29 include fast turnaround time, the use of recombinant antigens without elaborate purification 30 schemes, and ease of optimization. 3 Here, we demonstrate the power of synthetic biology 31 coupled with the LIPS immunoassay as a novel, rapid method to detect allergen-specific IgE in 32 low-volume samples. heterogeneous, the sensitivity and specificity of the LIPS assay for identifying cat IgE was 82 similar to that reported for aeroallergen skin prick testing. 4 We did not have information 83 regarding skin prick sensitivity to cat or clinical symptoms following cat exposure for our cohort; it is possible that the efficacy of LIPS would be increased if our analysis had been able to include 85 these parameters. 86 For Fel d 1, the LU correlated with cat IgE levels by ImmunoCAP. This is consistent 87 with studies showing that Fel d 1 is a reliable marker for cat sensitization and has high sensitivity 88 and specificity for clinical reactivity to cat. 5 antigens can be performed, 6 and components could be combined in a single assay to more 95 accurately determine allergen sensitivity. Indeed, we have piloted detection of IgE specific for 5 96 peanut components (data not shown).
97
The LIPS immunoassay offers a sensitive and efficient method to both qualitatively and 98 quantitatively determine an individual's sensitization patterns to major components of allergens, 99 using substantially less serum than is typically sent for a single allergen-specific IgE. This is of In addition to detection of specific IgE, LIPS may also be used to determine levels of 108 other antibody isotypes, such as IgG4 or IgA, specific to a particular allergen or allergen 109 component, simply by changing the isotype specificity of the antibody used to precipitate 110 antibody-protein complexes. 8 The LIPS assay may also be modified to evaluate for 111 quantification of components themselves, 9 
